tiprankstipranks
XTL Biopharmaceuticals Ltd. (IL:XTLB)
TASE:XTLB
Israel Market

Xtl Bio (XTLB) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Buy
11Bullish
2Neutral
8Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
4Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
XTL Biopharmaceuticals Ltd.’s (XTLB) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting XTL Biopharmaceuticals Ltd. is a Sell.
XTL Biopharmaceuticals Ltd.’s (XTLB) 20-Day exponential moving average is 1.81, while XTL Biopharmaceuticals Ltd.’s (XTLB) share price is 1.9, making it a Buy.
XTL Biopharmaceuticals Ltd.’s (XTLB) 50-Day exponential moving average is 1.95, while XTL Biopharmaceuticals Ltd.’s (XTLB) share price is 1.9, making it a Buy.

Xtl Bio (XTLB) Pivot Points

Jun 24, 2026, 04:13 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.80
1.80
1.80
1.80
1.80
1.80
1.80
Fibonacci
1.80
1.80
1.80
1.80
1.80
1.80
1.80
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Xtl Bio (XTLB) Moving Averages

Jun 24, 2026, 04:13 AM
Period
Simple
Exponential
MA5
1.82Buy
1.85Buy
MA10
1.76Buy
1.80Buy
MA20
1.76Buy
1.81Buy
MA50
1.97Buy
1.95Buy
MA100
2.20Sell
2.23Sell
MA200
2.88Sell
2.97Sell
XTL Biopharmaceuticals Ltd.’s (XTLB) 10-Day exponential moving average is 1.80, while XTL Biopharmaceuticals Ltd.’s (XTLB) share price is 1.9, making it a Buy.
XTL Biopharmaceuticals Ltd.’s (XTLB) 100-Day exponential moving average is 2.23, while XTL Biopharmaceuticals Ltd.’s (XTLB) share price is 1.9, making it a Sell.
XTL Biopharmaceuticals Ltd.’s (XTLB) stock price is 1.9 and XTL Biopharmaceuticals Ltd.’s (XTLB) 50-day simple moving average is 1.97, creating a Buy signal.
XTL Biopharmaceuticals Ltd.’s (XTLB) stock price is 1.9 and XTL Biopharmaceuticals Ltd.’s (XTLB) 100-day simple moving average is 2.20, creating a Sell signal.
XTL Biopharmaceuticals Ltd.’s (XTLB) stock price is 1.9 and XTL Biopharmaceuticals Ltd.’s (XTLB) 200-day simple moving average is 2.88, creating a Sell signal.

Xtl Bio (XTLB) Technical Indicators

Jun 24, 2026, 04:13 AM
Name
Value
Implied Action
RSI (14)
58.84
Neutral
STOCH (9,6)
100.00
Sell
STOCHRSI (14)
100.00
Sell
MACD (12,26)
-0.04
Sell
ADX (14)
16.88
Buy
Williams %R
0.00
Buy
CCI (14)
250.00
Sell
ATR (14)
0.12
-
Ultimate Oscillator
53.81
Neutral
ROC
17.65
Buy
XTL Biopharmaceuticals Ltd.’s (XTLB) Relative Strength Index (RSI) is 58.84, creating a Neutral signal.
XTL Biopharmaceuticals Ltd.’s (XTLB) Trend Strength Indicator (ADX) is 16.88, creating a Buy signal.
XTL Biopharmaceuticals Ltd.’s (XTLB) Commodity Channel Index (CCI) is 250.00, creating a Sell signal.
XTL Biopharmaceuticals Ltd.’s (XTLB) Price Rate of Change (ROC) is 17.65, creating a Buy signal.

FAQ

Is XTLB a Buy, Hold, or Sell?
Based on XTLB’s technical indicators, XTLB is a Buy.
    What is XTLB’s RSI (14)?
    XTLB’s RSI (14) is 58.84, which suggests XTLB is a Neutral.
      What is XTLB’s MACD?
      XTLB’s MACD is -0.04, which suggests XTLB is a Sell.
        What is XTLB’s 5-day moving average?
        XTLB’s 5-day moving average is 1.82, which suggests XTLB is a Buy.
          What is XTLB’s 20-day moving average?
          XTLB 20-day moving average is 1.76, which suggests XTLB is a Buy.
            What is XTLB’s 50-day moving average?
            XTLB’s 50-day moving average is 1.97, which suggests XTLB is a Buy.
              What is XTLB’s 200-day moving average?
              XTLB’s 200-day moving average is 2.88, which suggests XTLB is a Sell.
                What is XTLB’s Williams % R (14)?
                XTLB’s Williams % R (14) is 0.00, which suggests XTLB is a Buy.
                  What is XTLB’s CCI (14)?
                  XTLB’s CCI (14) is 250.00, which suggests XTLB is a Sell.
                    What is the share price of XTL Biopharmaceuticals Ltd.?